Attending the 2025 ASMS Conference? Schedule a meeting with ImmPro experts about yours needs and learn how our ProteoSight™ platform is redefining what’s possible in protein analysis.

We’re proud to launch our high-throughput AAV empty/full capsid assay—now available to support gene therapy developers.

Using automated Charge Detection Mass Spectrometry (CDMS), ImmPro delivers direct, accurate measurement of individual AAV capsids to quantify empty, full, and partially filled particles.